Applied BioCode Corporation

TWSE:6598.TW

22.65 (TWD) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) TWD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q22015 Q4
Revenue 101.63581.502128.229105.75378.47882.709120.736107.765107.75154.05109.52658.77667.79783.863138.50997.40511.68251.41925.81933.47719.29826.09916.854.4887.9047.9048.5378.5374.8414.84101.6530
Cost of Revenue 51.18740.49936.65534.41337.39329.47447.36241.86435.9930.91633.37730.52738.54428.14740.90632.6998.67323.21314.35617.68212.0997.62710.4292.6283.6783.6785.9245.9242.9972.99701.4680
Gross Profit 50.44841.00391.57471.3441.08553.23573.37465.90171.76123.13476.14928.24929.25355.71697.60364.7063.00928.20611.46315.7957.19918.4726.4211.864.2264.2262.6132.6131.8441.84400.1850
Gross Profit Ratio 0.4960.5030.7140.6750.5240.6440.6080.6120.6660.4280.6950.4810.4310.6640.7050.6640.2580.5490.4440.4720.3730.7080.3810.4140.5350.5350.3060.3060.3810.38100.1120
Reseach & Development Expenses 65.31870.1669.79160.63257.55961.91760.85261.24259.79256.48457.50550.7148.18649.45350.18249.0151.46446.34942.99949.71856.56967.64748.48653.81946.70246.70245.47945.47956.79456.794036.7150
General & Administrative Expenses 27.06826.13531.88432.23427.94525.88829.76828.87525.56124.81924.18425.21621.75320.36219.52821.56727.82616.87117.03914.86522.25219.2617.45719.6812.71412.71412.34612.34613.28413.28408.90
Selling & Marketing Expenses 24.80824.74516.49227.91622.94319.95122.11122.40118.84516.02418.01113.77114.34810.81113.97811.4468.76110.0567.41718.6765.2136.3478.3025.9616.0376.0375.415.413.073.0702.3840
SG&A 40.93740.08236.87360.1550.88845.83951.87951.27644.40640.84342.19538.98736.10131.17333.50633.01336.58726.92724.45633.54127.46525.60725.75925.64118.75118.75117.75617.75616.35316.353011.2840
Other Expenses 0.3530.6791.1210.2780.493-0.4260.30.8460.6740.347-1.8870.3750.2150.82332.95-5.5713.0821.7741.1130.1980.2650.0370.2540.061000000000
Operating Expenses 106.255110.242106.664120.782108.447107.756112.731112.518104.19897.32799.789.69784.28780.62683.68882.02388.05173.27667.45583.25984.03493.25474.24579.4665.56365.56363.69163.69172.89172.891047.8590
Operating Income -55.807-69.239-15.09-42.982-60.499-49.417-34.541-43.316-30.941-73.128-24.728-60.419-54.004-23.15548.306-22.208-81.96-43.296-54.879-67.266-76.57-74.745-67.57-77.539-61.228-61.228-60.622-60.622-71.303-71.3030-47.8140
Operating Income Ratio -0.549-0.85-0.118-0.406-0.771-0.597-0.286-0.402-0.287-1.353-0.226-1.028-0.797-0.2760.349-0.228-7.016-0.842-2.126-2.009-3.968-2.864-4.01-17.277-7.747-7.747-7.101-7.101-14.729-14.7290-28.9260
Total Other Income Expenses Net 5.8256.1196.518-0.739-0.635-0.597-0.67-0.796-0.62-0.698-0.721-0.676-0.713-0.76-0.797-0.863-1.175-1.479-2.583-1.663-2.207-0.136-0.401-0.2-0.058-0.058-0.05-0.050.2560.25600.140
Income Before Tax -49.982-63.12-8.572-43.721-61.134-50.014-35.211-44.112-31.561-73.826-25.449-61.095-54.717-23.91547.509-23.071-83.135-44.775-57.462-68.929-78.777-74.881-67.971-77.739-61.286-61.286-60.671-60.671-71.047-71.0470-47.6740
Income Before Tax Ratio -0.492-0.774-0.067-0.413-0.779-0.605-0.292-0.409-0.293-1.366-0.232-1.039-0.807-0.2850.343-0.237-7.117-0.871-2.226-2.059-4.082-2.869-4.034-17.322-7.754-7.754-7.107-7.107-14.676-14.6760-28.8410
Income Tax Expense 0.025-00.0060.0090.0280.7150.670.7960.02300.023000000.02400.012-0.0010.0070.0060.01200.0060.0060.0060.0060.0060.00600.3170
Net Income -50.007-63.12-8.578-43.73-61.162-50.729-35.881-44.908-31.584-73.826-25.472-61.095-54.717-23.91547.509-23.071-83.159-44.775-57.474-68.928-78.784-74.887-67.983-77.739-61.292-61.292-60.677-60.677-71.053-71.0530-47.3570
Net Income Ratio -0.492-0.774-0.067-0.414-0.779-0.613-0.297-0.417-0.293-1.366-0.233-1.039-0.807-0.2850.343-0.237-7.119-0.871-2.226-2.059-4.082-2.869-4.035-17.322-7.755-7.755-7.108-7.108-14.677-14.6770-28.6490
EPS -0.58-0.77-0.1-0.53-0.75-0.62-0.44-0.55-0.39-0.9-0.31-0.75-0.67-0.290.65-0.28-1.12-0.62-0.81-1.11-1.27-1.21-1.14-1.53-1.21-1.21-1.3-1.3-1.53-1.530-1.180
EPS Diluted -0.58-0.77-0.1-0.53-0.75-0.62-0.44-0.55-0.39-0.9-0.31-0.75-0.67-0.290.65-0.28-1.12-0.62-0.81-1.11-1.27-1.21-1.14-1.53-1.21-1.21-1.3-1.3-1.53-1.530-1.180
EBITDA -40.479-53.780.976-26.932-44.918-34.43-19.35-28.915-17.141-60.008-11.76-47.384-41.462-10.74159.344-10.169-71.164-33.574-45.61-57.798-67.783-69.461-62.754-73.362-57.487-57.487-57.277-57.277-68.216-68.2160-45.1670
EBITDA Ratio -0.398-0.660.008-0.255-0.572-0.416-0.16-0.268-0.159-1.11-0.107-0.806-0.612-0.1280.428-0.104-6.092-0.653-1.767-1.726-3.512-2.661-3.724-16.346-7.274-7.274-6.709-6.709-14.091-14.0910-27.3240